Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Go back to Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
StemCells, Inc. (NASDAQ: TEM) Delayed: 46.01 -0.95 (2.02%)
Previous Close $46.96    52 Week High $0.45 
Open $46.10    52 Week Low $0.37 
Day High $47.54    P/E N/A 
Day Low $45.51    EPS $-0.31 
Volume 4,350,479